Epigral to discuss Q2 FY27 results with investors

Epigral to discuss Q2 FY27 results with investors as part of an analyst and institutional investor meet scheduled for 2nd November, 2026. The session will provide insights into the company's performance and outlook. No new financial figures or guidance were disclosed in the filing. The event is primarily informational for market participants.

📊 STOCKS: $EPIGRAL | 🏢 SECTOR: CapitalMarkets | #LOWIMPACT #Earnings